Incumbent-intelligence read on this vehicle: who holds it, how the money has moved, and where the option runway opens the next recompete.
UNCLASSIFIED // COMPANY PROPRIETARY
Prepared August 1, 2026. Information available as of August 1, 2026. Built entirely from public federal records. All portions of this product are marked (U). Analysis is derived from public records, not verified fact; verify independently before relying on it. Handle as company proprietary.
Evidence Markings
DETERMINED: an observed fact from the public record.
INFERRED: an analytic judgment, carrying a stated confidence level.
MUST-CHECK: an intelligence gap, written as an action item for the capture team.
Confidence Scale
High: corroborated by multiple independent public sources; minimal inference.
Moderate: credibly sourced but not fully corroborated, or partial inference.
Low: fragmented, uncorroborated, or assumption-heavy.
Public preview: the holder roster and vehicle ceiling are free. A free account unlocks more; subscriptions are coming soon.Sign up freePricing
◎ Contract Vehicle SITREP
Analysis derived from public records, not verified fact. Verify independently before relying on it.
75N93024D00041
Incumbent-intelligence read on this vehicle: who holds it, how the money has moved, and where the option runway opens the next recompete.
Single-award IDIQ (IDC) · Single award · Department of Health and Human Services, NATIONAL INSTITUTES OF HEALTH NIAID
$5.9B ceiling40 holdersNAICS 541714
§1
Bottom Line Up Front
▪What this is. 75N93024D00041 is a single-award idiq (IDC) issued by Department of Health and Human Services, NATIONAL INSTITUTES OF HEALTH NIAID, solicitation NIHAI75N93023R00003, a single award vehicle with a combined ceiling of $5.9B, held by 40 primes on the public record.
▪The money. Funded totals against the $5.9B ceiling, split by prime, are a subscription read; the holder roster is on the public record below.
▪Recompete timing. No period-of-performance end is on record for this vehicle; recompete timing is not determined.
▪The read. For a challenger: the holder roster below is the field to beat, and the option runway sets the earliest realistic entry point. For an incumbent: defend the funded share and the option ladder now, and watch for deobligations or thinning competition as an early signal of a scope change.
§2
Entity Baseline
What this vehicle is and its scale, from the public contract record. Raw identifiers live here and in Sourcing; the body refers to the vehicle and its holders by name.
Vehicle
75N93024D00041
Type
Single-award IDIQ (IDC)
Award structure
Single award
Awarding agency / office
Department of Health and Human Services, NATIONAL INSTITUTES OF HEALTH NIAID
Combined ceiling
$5.9B
Funded to date
available with subscription
Period through
n/a
Base solicitation
NIHAI75N93023R00003
NAICS / PSC
541714 · PSC AN11
Vehicle ID
§3
Incumbent Baseline · Prime Roster
Every prime holder on the vehicle, from public contract award records. These are the incumbents a challenger displaces and the field most likely to defend.
🔒 Funded share, task orders, and corporate history
Funded position by prime, the fiscal-year obligation curve, order-level detail with options and deobligations, novation history, competition intensity, teaming, and how this buying office competes the category overall. Paid plans read the contract action records.
Who actually places orders under this vehicle, from public contract award records.
Agencies
No agencies with recorded orders under this vehicle yet.
Offices
No offices with recorded orders under this vehicle yet.
§6
Key Analytic Assessments
DETERMINEDHigh confidence
The incumbent roster is on the public record. This vehicle is a 40-holder multiple-award family with a combined ceiling of $5.9B, held by MRIGLOBAL, AMERICAN TYPE CULTURE COLLECTION, BATTELLE MEMORIAL INSTITUTE, AMERICAN FOUNDATION FOR BIOLOGICAL RESEARCH, BIOQUAL, INC., THE CHARLES STARK DRAPER LABORATORY, INC., COLORADO STATE UNIVERSITY, MINISTRY OF DEFENCE, EMORY UNIVERSITY, IIT RESEARCH INSTITUTE, INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC., PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD., SAINT LOUIS UNIVERSITY, SIGMOVIR BIOSYSTEMS, INC., SOUTHERN RESEARCH INSTITUTE, JACKSON LABORATORY, PENNSYLVANIA STATE UNIVERSITY, UNIVERSITY OF TENNESSEE, UK HEALTH SECURITY AGENCY, CINCINNATI UNIV OF, UNIVERSITY OF FLORIDA, UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC., UNIVERSITY OF LOUISVILLE, THE UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH, UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, UNIVERSITY OF SASKATCHEWAN, UNIVERSITY OF SOUTH ALABAMA, UTAH STATE UNIVERSITY, UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON, TEXAS BIOMEDICAL RESEARCH INSTITUTE, UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, UNIVERSITY OF CHICAGO, TRUSTEES OF TUFTS COLLEGE, THE ADMINISTRATORS OF TULANE EDUCATIONAL FUND, THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO, THE JOHNS HOPKINS UNIVERSITY, MIMETAS US INC., TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE, REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE.
MUST-CHECKintelligence gap
Successor vehicle structure. Whether this vehicle re-competes as a standalone follow-on or the requirement migrates onto a different GWAC or Schedule path is not established on the public record.
§7
Intelligence Gaps & Outlook
What this SITREP could not determine from the public record, consolidated. Each is an action for the capture team.
▸Exact option end and extensions. the option ladder shown reflects exercised actions on record; the contractual final option end date and any bilateral extensions are a solicitation-document pull, not a public contract-action fact.
▸Successor vehicle structure. whether this scope re-competes as a standalone follow-on, a new GWAC lane, or an existing Schedule path is unposted until the buying office publishes it.
▸Past-performance attribution on novated seats. how a recompete evaluation would score incumbency acquired by novation is an RFP and legal question, not a settled public-record fact.
▸Teaming beyond the reported floor. first-tier subcontract reporting is thresholded and under-reported; mentor-protege and joint-venture ties are not in these records.
▸Current SAM size and status of every holder. business size and socioeconomic standing reflect each holder's registration on file; confirm the current size rep for any specific target NAICS before relying on set-aside eligibility.
INFERRED
§8
Sourcing
All findings derive from public federal records, as of Sat Aug 01. Raw identifiers live here and in the Entity Baseline.
Federal contract award records (FPDS / USASpending), vehicle 75N93024D00041, contract ID CONT_IDV_75N93024D00041_7529, Department of Health and Human Services, NATIONAL INSTITUTES OF HEALTH NIAID, NAICS 541714, PSC AN11, combined ceiling $5.9B.
Federal contract action records (FPDS / USASpending), incumbent holders: MRIGLOBAL (contract 75N93024D00015, UEI HKQHNFKNKL15, ceiling $146M); AMERICAN TYPE CULTURE COLLECTION (contract 75N93024D00004, UEI KT4MLLHK99V6, ceiling $146M); BATTELLE MEMORIAL INSTITUTE (contract 75N93024D00005, UEI F125YU6SWK59, ceiling $146M); AMERICAN FOUNDATION FOR BIOLOGICAL RESEARCH (contract 75N93024D00006, UEI PT82EFQ7AL94, ceiling $146M); BIOQUAL, INC. (contract 75N93024D00007, UEI CK9LGQ7EBNN8, ceiling $146M); THE CHARLES STARK DRAPER LABORATORY, INC. (contract 75N93024D00008, UEI GTJHZE4M7YK1, ceiling $146M); COLORADO STATE UNIVERSITY (contract 75N93024D00009, UEI LT9CXX8L19G1, ceiling $146M); MINISTRY OF DEFENCE (contract 75N93024D00010, UEI U6LDUQKZ2CS8, ceiling $146M); EMORY UNIVERSITY (contract 75N93024D00011, UEI S352L5PJLMP8, ceiling $146M); IIT RESEARCH INSTITUTE (contract 75N93024D00012, UEI DGBUFQYMKWB5, ceiling $146M); INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. (contract 75N93024D00013, UEI Z82HHPY83MC7, ceiling $146M).
◎ CONTRACT VEHICLE SITREP // UNCLASSIFIED // COMPANY PROPRIETARY
Investigate|Radar|Illustrative intelligence from public data; supports, does not replace, your capture decision. The live record on SAM and USASpending always governs.
DETERMINEDHigh confidence40 prime holder(s) on the vehicle
MUST-CHECKintelligence gap
Teaming coverage is partial. First-tier subcontract reporting is required only above a dollar threshold and many primes under-report, so any teaming picture is a floor, not the full bench.
Moderate confidence
outlook
Short to medium term: the prime roster above defends its position on the vehicle, with the option runway setting the near-term recompete clock. The watch items that move this read are any RFP or successor-vehicle notice under this office and NAICS, new teaming that signals a bid, and a change in the funded-share leader.